Turk Ilac ve Serum Sanayi AS (TRILC) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.023x

Based on the latest financial reports, Turk Ilac ve Serum Sanayi AS (TRILC) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL44.50 Million ≈ $996.76K USD) by net assets (TL1.91 Billion ≈ $42.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Turk Ilac ve Serum Sanayi AS - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how Turk Ilac ve Serum Sanayi AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Turk Ilac ve Serum Sanayi AS total liabilities for a breakdown of total debt and financial obligations.

Turk Ilac ve Serum Sanayi AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Turk Ilac ve Serum Sanayi AS ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Delorean Corporation Ltd AU:DEL	-0.423x
Cheetah Holdings Bhd KLSE:7209	-0.096x
Akritas S.A AT:AKRIT	-0.137x
Bengal Energy Ltd TO:BNG	-0.004x
Ata Gayrimenkul Yatirim Ortakligi AS IS:ATAGY	-0.002x
Altamin Ltd AU:AZI	-0.491x
Temple Bar Investment Trust LSE:TMPL	0.018x
Airo Lam limited NSE:AIROLAM	0.083x

Annual Cash Flow Conversion Efficiency for Turk Ilac ve Serum Sanayi AS (2018–2024)

The table below shows the annual cash flow conversion efficiency of Turk Ilac ve Serum Sanayi AS from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see Turk Ilac ve Serum Sanayi AS stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	TL1.92 Billion ≈ $43.09 Million	TL-378.48 Million ≈ $-8.48 Million	-0.197x	-185.55%
2023-12-31	TL1.78 Billion ≈ $39.76 Million	TL408.19 Million ≈ $9.14 Million	0.230x	+1193.03%
2022-12-31	TL564.69 Million ≈ $12.65 Million	TL-11.88 Million ≈ $-266.08K	-0.021x	+90.49%
2021-12-31	TL324.08 Million ≈ $7.26 Million	TL-71.67 Million ≈ $-1.61 Million	-0.221x	-198.67%
2020-12-31	TL148.13 Million ≈ $3.32 Million	TL33.20 Million ≈ $743.59K	0.224x	+9.86%
2019-12-31	TL65.28 Million ≈ $1.46 Million	TL13.32 Million ≈ $298.28K	0.204x	-66.57%
2018-12-31	TL62.47 Million ≈ $1.40 Million	TL38.13 Million ≈ $853.93K	0.610x	--

About Turk Ilac ve Serum Sanayi AS

IS:TRILC Turkey Drug Manufacturers - Specialty & Generic

Market Cap

$14.02 Million

TL626.19 Million TRY

Market Cap Rank

#26016 Global

#465 in Turkey

Share Price

TL3.87

Change (1 day)

-3.49%

52-Week Range

TL3.24 - TL25.26

All Time High

TL37.80